,studlab,treat1,treat2,TE,seTE,n1,mean1,sd1,n2,mean2,sd2,studlab.orig,author,year,rob,effect_size1,outcome1_direction,treat.orig1,treat.orig2,r1,r2,n.orig1,n.orig2,y1,y2,sd.orig1,sd.orig2
0,1,Salmeterol,Placebo,-0.1,0.029578732400000002,229,1.2,0.4,227,1.3,0.2,1,Boyd 1997,2023,1,MD,beneficial,Salmeterol,Placebo,1,1,229,227,1.2,1.3,0.4,0.2
1,2,Fluticasone,Salmeterol,-2.6,0.0073225466,374,0.5,0.1,372,3.1,0.1,2,Calverly 2003,2021,1,MD,beneficial,Fluticasone,Salmeterol,4,3,374,372,0.5,3.1,0.1,0.1
2,3,SFC,Placebo,-0.4,0.0073195866000000005,358,0.7000000000000001,0.07,361,1.1,0.12,3,Calverly 2003,2020,1,MD,beneficial,SFC,Placebo,2,7,358,361,0.7000000000000001,1.1,0.07,0.12
3,4,Salmeterol,Placebo,-0.2,0.020137912,554,1.2,0.2,270,1.4,0.30000000000000004,4,Celli 2003,2020,1,MD,beneficial,Salmeterol,Placebo,1,2,554,270,1.2,1.4,0.2,0.30000000000000004
